COVID-19 and immunosuppressive therapy in dermatology.
Dermatol Ther
; 33(6): e14140, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: covidwho-696651
ABSTRACT
Coronavirus 2019 (COVID 19) was first detected in December 2019 in China. It has become a pandemic. With concern about therapies that may decrease immunity and enhance the severity of an individual's COVID-19 infection, leading to a possibly fatal outcome, use of immunosuppressants has become an important concern. This work focuses on management of various skin diseases individuals lacking immunity to COVID-19 but requiring a systemic immunosuppressant, keeping in view the challenge of the COVID 19 pandemic and that our knowledge of this virus and its effects on the immune system are incomplete including knowledge as to an individual's immunity after COVID-19 infection.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Enfermedades de la Piel
/
COVID-19
/
Inmunosupresores
Tipo de estudio:
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
Dermatol Ther
Asunto de la revista:
Dermatologia
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
Dth.14140
Similares
MEDLINE
...
LILACS
LIS